ENZ logo

Enzo Biochem (ENZ) Long Term Liabilities

Annual Total Long Term Liabilities

$4.86 M
+$1.43 M+41.67%

July 31, 2024

Summary

Performance

1-Year Change

+41.67%

3-Year Change

-74.47%

5-Year Change

+5.54%

15-Year Change

+394.2%

ENZ Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.26%
ENZ annual total long term liabilities is higher than 35.26% of companies in Healthcare sector

High & Low

All-time High

$54.00 M
ENZ annual total long term liabilities is currently -91.00% below its historical high of $54.00 million

3-Year Low

$3.43 M
ENZ annual total long term liabilities is currently +41.67% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jul 31, 2024
ENZ previous annual earnings announcement was published on Jul 31, 2024

Next Annual Earnings Report Date

N/A
ENZ next annual earnings announcement has not yet been scheduled

OtherENZbalance sheetmetrics:

Annual Total Liabilities

$29.65 M
ENZ annual total liabilities is $29.65 million

Annual Current Liabilities

$24.79 M
ENZ annual total current liabilities is $24.79 million

Annual Total Assets

$85.76 M
ENZ annual total assets is $85.76 million

Annual Current Assets

$70.03 M
ENZ annual total current assets is $70.03 million

Quarterly Long Term Liabilities

$4.24 M
-$622.00 K-12.80%

October 31, 2024

Summary

Performance

3-Month Change

-12.8%

1-Year Change

-12.8%

3-Year Change

-76.82%

5-Year Change

-79.71%

ENZ Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.17%
ENZ quarterly total long term liabilities is higher than 36.17% of companies in Healthcare sector

High & Low

All-time High

$54.00 M
ENZ quarterly total long term liabilities is currently -92.16% below its historical high of $54.00 million

3-Year Low

$2.77 M
ENZ quarterly total long term liabilities is currently +52.65% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
ENZ previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
ENZ next earnings announcement is scheduled for Mar 13, 2025

OtherENZbalance sheetmetrics:

Quarterly Total Liabilities

$27.63 M
ENZ quarterly total liabilities is $27.63 million

Quarterly Current Liabilities

$23.40 M
ENZ quarterly total current liabilities is $23.40 million

Quarterly Total Assets

$75.29 M
ENZ quarterly total assets is $75.29 million

Quarterly Current Assets

$59.66 M
ENZ quarterly total current assets is $59.66 million

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

Annual Total Long Term Liabilities

$4.86 M
ENZ annual total long term liabilities is $4.86 million

Annual Long Term Debt

$2.59 M
ENZ annual long term debt is $2.59 million

ENZ Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+41.7%-12.8%
3 y3 years-74.5%-76.8%
5 y5 years+5.5%-79.7%

ENZ Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-74.5%+41.7%-75.9%+52.6%
5 y5-year-77.3%+41.7%-81.4%+52.6%
alltimeall time-91.0%+1276.2%-92.2%+2724.0%

Enzo Biochem Long Term Liabilities History

DateAnnualQuarterly
Oct 2024
-
$4.24 M(-12.8%)
Jul 2024
$4.86 M(+41.7%)
$4.86 M(+75.1%)
Apr 2024
-
$2.77 M(-8.1%)
Jan 2024
-
$3.02 M(-5.4%)
Oct 2023
-
$3.19 M(-6.9%)
Jul 2023
$3.43 M(-57.8%)
$3.43 M(-68.8%)
Apr 2023
-
$10.98 M(-3.9%)
Jan 2023
-
$11.42 M(-28.4%)
Oct 2022
-
$15.96 M(+96.3%)
Jul 2022
$8.13 M(-57.3%)
$8.13 M(-52.2%)
Apr 2022
-
$17.02 M(-3.0%)
Jan 2022
-
$17.55 M(-4.0%)
Oct 2021
-
$18.27 M(-4.0%)
Jul 2021
$19.03 M(-10.9%)
$19.03 M(-2.1%)
Apr 2021
-
$19.44 M(-4.2%)
Jan 2021
-
$20.29 M(-2.8%)
Oct 2020
-
$20.88 M(-2.2%)
Jul 2020
$21.36 M(+364.0%)
$21.36 M(-3.6%)
Apr 2020
-
$22.15 M(-2.5%)
Jan 2020
-
$22.72 M(-5.0%)
Oct 2019
-
$23.91 M(+419.4%)
Jul 2019
$4.60 M(+1204.0%)
$4.60 M(-2.7%)
Apr 2019
-
$4.73 M(-5.9%)
Jan 2019
-
$5.03 M(+1470.9%)
Oct 2018
-
$320.00 K(-9.3%)
Jul 2018
$353.00 K(-64.1%)
$353.00 K(-12.6%)
Apr 2018
-
$404.00 K(-18.4%)
Jan 2018
-
$495.00 K(-7.1%)
Oct 2017
-
$533.00 K(-45.8%)
Jul 2017
$983.00 K(-42.1%)
$983.00 K(-7.0%)
Apr 2017
-
$1.06 M(-3.7%)
Jan 2017
-
$1.10 M(-8.7%)
Oct 2016
-
$1.20 M(-29.2%)
Jul 2016
$1.70 M(-7.2%)
$1.70 M(-8.1%)
Apr 2016
-
$1.85 M(-5.5%)
Jan 2016
-
$1.96 M(+40.2%)
Oct 2015
-
$1.39 M(-23.8%)
Jul 2015
$1.83 M(-26.7%)
$1.83 M(-4.7%)
Apr 2015
-
$1.92 M(-3.6%)
Jan 2015
-
$1.99 M(-0.3%)
Oct 2014
-
$2.00 M(-20.0%)
Jul 2014
$2.50 M(+156.3%)
$2.50 M(+2.0%)
Apr 2014
-
$2.45 M(+172.9%)
Jan 2014
-
$897.00 K(-5.7%)
Oct 2013
-
$951.00 K(-2.4%)
Jul 2013
$974.00 K(-8.6%)
$974.00 K(-33.9%)
Apr 2013
-
$1.47 M(-1.2%)
Jan 2013
-
$1.49 M(+2.3%)
Oct 2012
-
$1.46 M(+36.8%)
Jul 2012
$1.07 M(-64.8%)
$1.07 M(-61.8%)
Apr 2012
-
$2.79 M(-1.1%)
Jan 2012
-
$2.82 M(-3.4%)
Oct 2011
-
$2.92 M(-3.7%)
Jul 2011
$3.03 M(+13.4%)
$3.03 M(+9.7%)
Apr 2011
-
$2.76 M(+1.8%)
Jan 2011
-
$2.71 M(+0.4%)
Oct 2010
-
$2.70 M(+1.2%)
Jul 2010
$2.67 M(+11.1%)
$2.67 M(+24.4%)
Apr 2010
-
$2.15 M(-2.6%)
Jan 2010
-
$2.21 M(-5.2%)
Oct 2009
-
$2.33 M(-3.2%)
Jul 2009
$2.40 M(-18.4%)
$2.40 M(+12.9%)
Apr 2009
-
$2.13 M(-5.5%)
Jan 2009
-
$2.25 M(-8.4%)
Oct 2008
-
$2.46 M(-16.5%)
Jul 2008
$2.94 M(+10.4%)
$2.94 M(+16.9%)
Apr 2008
-
$2.52 M(-5.8%)
Jan 2008
-
$2.67 M(-3.5%)
Oct 2007
-
$2.77 M(+3.9%)
Jul 2007
$2.67 M
$2.67 M(+154.0%)
Apr 2007
-
$1.05 M(+600.0%)
DateAnnualQuarterly
Jan 2006
-
$150.00 K(0.0%)
Oct 2005
-
$150.00 K(-63.4%)
Jul 2005
$410.00 K(-44.9%)
$410.00 K(-31.2%)
Apr 2005
-
$596.00 K(+30.7%)
Jan 2005
-
$456.00 K(-35.0%)
Oct 2004
-
$702.00 K(-5.6%)
Jul 2004
$744.00 K(-43.7%)
$744.00 K(-28.9%)
Apr 2004
-
$1.05 M(-2.4%)
Jan 2004
-
$1.07 M(-7.3%)
Oct 2003
-
$1.16 M(-12.5%)
Jul 2003
$1.32 M(-22.0%)
$1.32 M(-14.6%)
Apr 2003
-
$1.55 M(-3.1%)
Jan 2003
-
$1.60 M(-3.0%)
Oct 2002
-
$1.65 M(-2.9%)
Jul 2002
$1.70 M(-18.0%)
$1.70 M(-12.9%)
Apr 2002
-
$1.95 M(-2.0%)
Jan 2002
-
$1.99 M(-2.0%)
Oct 2001
-
$2.03 M(-1.9%)
Jul 2001
$2.07 M(-0.9%)
$2.07 M(+48.2%)
Apr 2001
-
$1.40 M(-1.7%)
Jan 2001
-
$1.42 M(-2.3%)
Oct 2000
-
$1.45 M(-30.3%)
Jul 2000
$2.09 M(+131.8%)
$2.09 M(+151.3%)
Apr 2000
-
$830.00 K(-7.8%)
Jan 2000
-
$900.00 K(0.0%)
Oct 1999
-
$900.00 K(0.0%)
Jul 1999
$900.00 K(-10.0%)
$900.00 K(0.0%)
Apr 1999
-
$900.00 K(-10.0%)
Jan 1999
-
$1.00 M(0.0%)
Oct 1998
-
$1.00 M(0.0%)
Jul 1998
$1.00 M(0.0%)
$1.00 M(+11.1%)
Apr 1998
-
$900.00 K(-10.0%)
Jan 1998
-
$1.00 M(0.0%)
Oct 1997
-
$1.00 M(0.0%)
Jul 1997
$1.00 M(0.0%)
$1.00 M(-9.1%)
Apr 1997
-
$1.10 M(+10.0%)
Jan 1997
-
$1.00 M(-9.1%)
Oct 1996
-
$1.10 M(+10.0%)
Jul 1996
$1.00 M(-82.1%)
$1.00 M(-82.1%)
Apr 1996
-
$5.60 M(-3.4%)
Jan 1996
-
$5.80 M(+3.6%)
Oct 1995
-
$5.60 M(0.0%)
Jul 1995
$5.60 M(+7.7%)
$5.60 M(+5.7%)
Apr 1995
-
$5.30 M(+1.9%)
Jan 1995
-
$5.20 M(-1.9%)
Oct 1994
-
$5.30 M(+1.9%)
Jul 1994
$5.20 M(+4.0%)
$5.20 M(+4.0%)
Apr 1994
-
$5.00 M(0.0%)
Jan 1994
-
$5.00 M(-39.0%)
Oct 1993
-
$8.20 M(+64.0%)
Jul 1993
$5.00 M(+6.4%)
$5.00 M(0.0%)
Apr 1993
-
$5.00 M(+4.2%)
Jan 1993
-
$4.80 M(0.0%)
Oct 1992
-
$4.80 M(+2.1%)
Jul 1992
$4.70 M(-2.1%)
$4.70 M(-14.5%)
Apr 1992
-
$5.50 M(+1.9%)
Jan 1992
-
$5.40 M(+1.9%)
Oct 1991
-
$5.30 M(+10.4%)
Jul 1991
$4.80 M(-90.0%)
$4.80 M(-68.4%)
Apr 1991
-
$15.20 M(-64.3%)
Jan 1991
-
$42.60 M(-11.8%)
Oct 1990
-
$48.30 M(+0.2%)
Jul 1990
$48.20 M(-10.7%)
$48.20 M(-8.7%)
Apr 1990
-
$52.80 M(-0.4%)
Jan 1990
-
$53.00 M(-1.1%)
Oct 1989
-
$53.60 M(-0.7%)
Jul 1989
$54.00 M(+11.6%)
$54.00 M(+11.6%)
Jul 1988
$48.40 M(-1.8%)
$48.40 M(-1.8%)
Jul 1987
$49.30 M(+1.2%)
$49.30 M(+1.2%)
Jul 1986
$48.70 M(+3958.3%)
$48.70 M(+3958.3%)
Jul 1984
$1.20 M
$1.20 M

FAQ

  • What is Enzo Biochem annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Enzo Biochem?
  • What is Enzo Biochem annual total long term liabilities year-on-year change?
  • What is Enzo Biochem quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Enzo Biochem?
  • What is Enzo Biochem quarterly long term liabilities year-on-year change?

What is Enzo Biochem annual total long term liabilities?

The current annual total long term liabilities of ENZ is $4.86 M

What is the all time high annual total long term liabilities for Enzo Biochem?

Enzo Biochem all-time high annual total long term liabilities is $54.00 M

What is Enzo Biochem annual total long term liabilities year-on-year change?

Over the past year, ENZ annual total long term liabilities has changed by +$1.43 M (+41.67%)

What is Enzo Biochem quarterly total long term liabilities?

The current quarterly long term liabilities of ENZ is $4.24 M

What is the all time high quarterly long term liabilities for Enzo Biochem?

Enzo Biochem all-time high quarterly total long term liabilities is $54.00 M

What is Enzo Biochem quarterly long term liabilities year-on-year change?

Over the past year, ENZ quarterly total long term liabilities has changed by -$622.00 K (-12.80%)